Esperion Therapeutics, Daiichi Sankyo Europe Ink $125 Mln Amendment To Their Collaboration

RTTNews | 432 dias atrás
Esperion Therapeutics, Daiichi Sankyo Europe Ink $125 Mln Amendment To Their Collaboration

(RTTNews) - Esperion Therapeutics, Inc. (ESPR) and Daiichi Sankyo Europe GmbH or DSE, the European arm of Japanese pharmaceutical company Daiichi Sankyo Co., Ltd. (DSKYF.PK), announced Wednesday a $125 million amendment to their collaboration, which includes an amicable resolution to their commercial dispute and certain other adjustments to enhance the long-term value of their products.

DSE has agreed to pay Esperion $100 million in mid-January ahead of an anticipated Type II(a) variation approval by the European Medicines Agency (EMA) for NILEMDO (bempedoic acid) Tablet and NUSTENDI (bempedoic acid and ezetimibe) Tablet.

DSE will make an additional $25 million payment to Esperion in the calendar quarter immediately following EMA's decision on the pending application.

The legal action pending in the United States District Court for the Southern District of New York will be dismissed.

Since 2019, Esperion and DSE have worked together to bring bempedoic acid to the eligible patient population and unlock its potential for cardiovascular risk reduction. The partnership continues to grow, with DSE recently gaining approvals for bempedoic acid in the Netherlands, Slovakia, and Spain.

read more
Merck, Daiichi Sankyo Say FDA Grants Priority Review In U.S. For Patritumab Deruxtecan

Merck, Daiichi Sankyo Say FDA Grants Priority Review In U.S. For Patritumab Deruxtecan

Merck & Co. Inc. (MRK) and Japan's Daiichi Sankyo Co. Ltd. (DSKYF.PK) announced Friday that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the Biologics License Application (BLA) for patritumab deruxtecan (HER3-DXd) for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) previously treated with two or more systemic therapies.
RTTNews | 444 dias atrás
Dollar Tumbles As Trade War Ignites Growth Fears

Dollar Tumbles As Trade War Ignites Growth Fears

The U.S. dollar tumbled against major currencies during the week ended March 7 amidst an extended sell-off on Wall Street triggered by the escalation in the trade war and a weak labor market update.
RTTNews | 7h 27min atrás
Bay Street Likely To Open On Weak Note

Bay Street Likely To Open On Weak Note

Canadian shares are likely to open on a negative note Monday morning amid fears of a U.S. recession, and rising concerns about China's growth outlook.
RTTNews | 7h 52min atrás
Yen Rises Amid Risk Aversion

Yen Rises Amid Risk Aversion

The Japanese yen strengthened against other major currencies in the European session on Monday, as the investor sentiment fell on lingering tariff worries, the threat of a U.S. recession and signs of deepening deflationary pressures in China.
RTTNews | 9h 7min atrás
Yen Rises Against Majors

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the European session on Tuesday.
RTTNews | 10h 13min atrás
FTSE 100 Slips After Positive Start, Down Nearly 0.6%

FTSE 100 Slips After Positive Start, Down Nearly 0.6%

After a positive start, U.K. stocks retreated Monday morning, with shares from banking sector recording notable losses. Concerns about the outlook for global economic growth and uncertainty about U.S. trade policy are hurting sentiment.
RTTNews | 10h 20min atrás
Sensex, Nifty Give Up Early Gains

Sensex, Nifty Give Up Early Gains

Indian shares ended slightly lower on Monday, failing to hold early gains due to uncertainty surrounding U.S. tariffs and signs of deepening deflationary pressures in China.
RTTNews | 10h 44min atrás
CAC 40 Modestly Lower In Cautious Trade

CAC 40 Modestly Lower In Cautious Trade

French stocks are exhibiting weakness Monday morning with investors making cautious moves amid concerns about growth and international trade due to continued uncertainty about the policies of the Trump Administration.
RTTNews | 10h 47min atrás